Louis K. Chang

2.6k total citations
37 papers, 2.1k citations indexed

About

Louis K. Chang is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Louis K. Chang has authored 37 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Ophthalmology, 16 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Molecular Biology. Recurrent topics in Louis K. Chang's work include Retinal Diseases and Treatments (20 papers), Retinal and Optic Conditions (15 papers) and Retinal and Macular Surgery (10 papers). Louis K. Chang is often cited by papers focused on Retinal Diseases and Treatments (20 papers), Retinal and Optic Conditions (15 papers) and Retinal and Macular Surgery (10 papers). Louis K. Chang collaborates with scholars based in United States, Canada and Australia. Louis K. Chang's co-authors include David Sarraf, Richard F. Spaide, Eugene M. Johnson, Sheri Fink, Robert M. Sapolsky, Dora Y. Ho, Hideki Koizumi, David M. Holtzman, Anne M. Fagan and Rahul N. Khurana and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Cell Biology.

In The Last Decade

Louis K. Chang

37 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louis K. Chang United States 22 988 754 709 526 221 37 2.1k
Ivan O. Haefliger Switzerland 23 1.6k 1.7× 500 0.7× 657 0.9× 496 0.9× 96 0.4× 91 2.2k
M. O.M. Tso United States 29 1.5k 1.5× 1.5k 1.9× 485 0.7× 169 0.3× 440 2.0× 61 2.7k
Nobuo Fuse Japan 25 1.0k 1.0× 778 1.0× 544 0.8× 109 0.2× 83 0.4× 86 1.9k
Elisa Dominguez France 13 434 0.4× 531 0.7× 123 0.2× 284 0.5× 187 0.8× 14 1.4k
Raffaele Mancino Italy 25 1.1k 1.1× 474 0.6× 607 0.9× 123 0.2× 93 0.4× 65 1.7k
Jharna Ray India 21 445 0.5× 1.3k 1.7× 166 0.2× 172 0.3× 387 1.8× 86 2.2k
Franziska vom Hagen Germany 17 493 0.5× 628 0.8× 197 0.3× 151 0.3× 92 0.4× 24 1.3k
Yasushi Kitaoka Japan 21 755 0.8× 628 0.8× 322 0.5× 98 0.2× 217 1.0× 72 1.4k
Anselm Jünemann Germany 22 1.1k 1.1× 414 0.5× 541 0.8× 66 0.1× 58 0.3× 77 1.6k
Marie‐Noëlle Delyfer France 26 1.4k 1.5× 493 0.7× 893 1.3× 61 0.1× 145 0.7× 109 2.0k

Countries citing papers authored by Louis K. Chang

Since Specialization
Citations

This map shows the geographic impact of Louis K. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis K. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis K. Chang more than expected).

Fields of papers citing papers by Louis K. Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis K. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis K. Chang. The network helps show where Louis K. Chang may publish in the future.

Co-authorship network of co-authors of Louis K. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Louis K. Chang. A scholar is included among the top collaborators of Louis K. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis K. Chang. Louis K. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, Clement K., Maziar Lalezary, Prema Abraham, et al.. (2022). Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration in Vulnerable Fellow Eyes. Ophthalmology Retina. 6(6). 484–494. 12 indexed citations
2.
Finn, Avni P., Rahul N. Khurana, & Louis K. Chang. (2021). Hemi-retinal vein occlusion in a young patient with COVID-19. American Journal of Ophthalmology Case Reports. 22. 101046–101046. 25 indexed citations
3.
Khurana, Rahul N., et al.. (2020). Timing of Peak Vision Gains in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab. Ophthalmology Retina. 4(8). 760–766. 2 indexed citations
4.
Khurana, Rahul N., et al.. (2019). The Value of Prior Response to Anti–Vascular Endothelial Growth Factor for Age-Related Macular Degeneration. Ophthalmology Retina. 4(1). 13–18. 1 indexed citations
5.
Khurana, Rahul N., Louis K. Chang, Alok Bansal, et al.. (2019). Treat and extend regimen with aflibercept for chronic central retinal vein occlusions: 2 year results of the NEWTON study. International Journal of Retina and Vitreous. 5(1). 10–10. 10 indexed citations
6.
Lalezary, Maziar, Steven Lin, Clement K. Chan, et al.. (2017). Prophylactic Ranibizumab for Exudative age-related macular degeneration (AMD) in Vulnerable Eyes with Non-Exudative AMD Trial (PREVENT): A prospective controlled clinical trial. Investigative Ophthalmology & Visual Science. 58(8). 410–410. 2 indexed citations
7.
Gregory-Roberts, Emily, Carlos Mateo, Borja Corcóstegui, et al.. (2012). OPTIC DISK PIT MORPHOLOGY AND RETINAL DETACHMENT. Retina. 33(2). 363–370. 30 indexed citations
8.
Vance, Sushma K, Louis K. Chang, Yutaka Imamura, & K. Bailey Freund. (2010). EFFECTS OF INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT ON RETINAL VASCULATURE IN RETINAL VEIN OCCLUSION AS DETERMINED BY ULTRA WIDE-FIELD FLUORESCEIN ANGIOGRAPHY. Retinal Cases & Brief Reports. 5(4). 343–347. 6 indexed citations
9.
Chang, Louis K., et al.. (2009). PERIPHERAL POLYPOIDAL CHOROIDAL NEOVASCULARIZATION, SUBRETINAL HEMORRHAGE, AND CATARACT SURGERY. Retinal Cases & Brief Reports. 3(4). 364–366. 3 indexed citations
10.
Chang, Louis K., et al.. (2008). UItrastructural Correlation of Spectral-Domain Optical Coherence Tomography Findings in Vitreomacular Traction Syndrome. Investigative Ophthalmology & Visual Science. 49(13). 4722–4722. 1 indexed citations
11.
Chiang, Allen, Louis K. Chang, Fei Yu, & David Sarraf. (2008). Predictors of AntiVEGF-Associated Retinal Pigment Epithelial Tear Using OCT and FA Analysis. Investigative Ophthalmology & Visual Science. 49(13). 5070–5070. 6 indexed citations
12.
Chang, Louis K.. (2008). Bevacizumab Treatment for Subfoveal Choroidal Neovascularization From Causes Other Than Age-Related Macular Degeneration. Archives of Ophthalmology. 126(7). 941–941. 61 indexed citations
13.
Chang, Louis K., Hideki Koizumi, & Richard F. Spaide. (2008). Disruption of the Photoreceptor Inner Segment–Outer Segment Junction in Eyes With Macular Holes. Retina. 28(7). 969–975. 100 indexed citations
14.
Chang, Louis K., Christina J. Flaxel, Andreas Lauer, & David Sarraf. (2007). RPE TEARS AFTER PEGAPTANIB TREATMENT IN AGE-RELATED MACULAR DEGENERATION. Retina. 27(7). 857–863. 51 indexed citations
15.
Ela-Dalman, Noa, Anthony C. Arnold, Louis K. Chang, Federico G. Velez, & Joseph L. Lasky. (2007). Abducens Nerve Ocular Neuromyotonia Following Non-sellar or Parasellar Tumors. Strabismus. 15(3). 149–151. 15 indexed citations
16.
Chang, Louis K., et al.. (2006). OCT Imaging of RPE Tears in Patients Receiving Treatment With Macugen for AMD–Related PED. Investigative Ophthalmology & Visual Science. 47(13). 2185–2185. 1 indexed citations
17.
Holtzman, David M., Kelly R. Bales, Shan Wu, et al.. (1999). Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease. Journal of Clinical Investigation. 103(6). R15–R21. 291 indexed citations
18.
Fagan, Anne M., David M. Holtzman, Gregory W. Munson, et al.. (1999). Unique Lipoproteins Secreted by Primary Astrocytes From Wild Type, apoE (−/−), and Human apoE Transgenic Mice. Journal of Biological Chemistry. 274(42). 30001–30007. 178 indexed citations
19.
Moulder, Krista L., Masaaki Narita, Louis K. Chang, Guojun Bu, & Eugene M. Johnson. (1999). Analysis of a Novel Mechanism of Neuronal Toxicity Produced by an Apolipoprotein E‐Derived Peptide. Journal of Neurochemistry. 72(3). 1069–1080. 33 indexed citations
20.
Yenari, Midori A., Sheri Fink, Guo Hua Sun, et al.. (1998). Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Annals of Neurology. 44(4). 584–591. 285 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivan O. Haefliger Breakdown of academic impact, for papers by M. O.M. Tso Breakdown of academic impact, for papers by Nobuo Fuse Breakdown of academic impact, for papers by Elisa Dominguez Breakdown of academic impact, for papers by Raffaele Mancino Breakdown of academic impact, for papers by Jharna Ray Breakdown of academic impact, for papers by Franziska vom Hagen Breakdown of academic impact, for papers by Yasushi Kitaoka Breakdown of academic impact, for papers by Anselm Jünemann Breakdown of academic impact, for papers by Marie‐Noëlle Delyfer
Rankless by CCL
2026